TITLE

Controlled Evaluation of Drugs in Chronic Vascular Disease

AUTHOR(S)
Tr�bestein, G.
PUB. DATE
October 1981
SOURCE
Angiology;Oct1981, Vol. 32 Issue 10, p699
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article cites a study on controlled evaluation of drugs in chronic vascular disease. Evaluation of drugs in chronic vascular disease presents both problems and contradictions. One finds many reports supporting administration of vasoactive drugs in chronic vascular disease as well as some which find no positive value in the use of these drugs. Development of collaterals in chronic vascular disease has been shown to take place after administration of vasoactive substances. Finally, it was concluded that the current methods available in clinics cannot determine clearly and reproducibly areas of minimal perfusion.
ACCESSION #
16397151

 

Related Articles

  • Reduced endothelial secretion and plasma levels of transforming growth factor-β1 in patients with hereditary hemorrhagic telangiectasia type 1. Letarte, Michelle; McDonald, Merry-Lynn; Li, Chenggang; Kathirkamathamby, Kirishanthy; Vera, Sonia; Pece-Barbara, Nadia; Kumar, Shant // Cardiovascular Research;Oct2005, Vol. 68 Issue 1, p155 

    Abstract: Objective: To determine if patients with hereditary hemorrhagic telangiectasia (HHT) show alterations in transforming growth factor (TGF)-β and its pathways. Methods: Blood samples were obtained from HHT patients and controls, while endothelial cells were derived from umbilical...

  • Images in vascular medicine. Sheikh, M.A.; Gomes, M.P.; Bartholomew, J.R. // Vascular Medicine;2001, Vol. 6 Issue 1, p63 

    abstract

  • Hipertensiune pulmonară severă la o pacientă tânără cu sindrom inflamator - particularităţi de diagnostic ÅŸi tratament. Jurcuţ, C.; Jurcuţ, Ruxandra; Ghiorghiu, Ioana; Predeţeanu, Denisa; Rugină, Mihaela; Copaci, I.; Ginghină, Carmen // Romanian Journal of Cardiology;Dec2009, Vol. 24 Issue 4, p301 

    We present the case of 25-year old young women with pulmonary arterial hypertension. The exhaustive investigations lead us, in the presence of systemic inflammatory syndrome, to the diagnostic of systemic lupus erythematosus. The treatment with pulmonary vasodilators (i.e. bosentan) and...

  • Aspirin: Different patients, different stroke risks. Pinkowish, Mary Desmond // Patient Care;4/30/2000, Vol. 34 Issue 8, p15 

    Presents a meta-analysis of the relationship between aspirin use and the risk of stroke and other vascular diseases conducted by University of Texas Professor of Medicine Robert Hart and colleagues from Canada and the United States. Effectiveness aspiring in reducing stroke risk in high-risk...

  • Aspirin may benefit more patients at risk for vascular disease.  // Geriatrics;Mar94, Vol. 49 Issue 3, p17 

    Reports on the efficacy of routine antiplatelet therapy with low-dose aspirin for patients at risk for occlusive vascular disease. Benefits of antiplatelet therapy in primary prevention; Reduction of nonfatal myocardial infarct.

  • Vasculitis.  // Current Medical Literature: Rheumatology;2008, Vol. 27 Issue 1, p31 

    This article research being done on the treatment of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. It references a study by X. Bosch et al., published in a 2007 issue of the "Journal of the American Medical Association." The authors performed a systematic literature review...

  • Iatrogenic Ergot Vasospastic Angiitis. A Case Report. Kapoor, O. P. // Vascular Surgery;Jan1976, Vol. 10 Issue 1, p58 

    Hydergin, a preparation composed of equal components of dihydroergocristine, dihydroergocryptine and dihydroergocornine has been used as a peripheral vasodilator. We have presented a case report, with arteriographic confirmation, in which, this drug has produced symptoms and signs of Iatrogenic...

  • The association of acute exercise-induced ischaemia with systemic vasodilator function in patients with peripheral arterial disease. Joras, Majda; Poredoš, Pavel // Vascular Medicine;2008, Vol. 13 Issue 4, p255 

    Patients with peripheral arterial disease (PAD) frequently experience ischaemic attacks of the affected tissues during exercise. The present study assesses the association of transient exercise-induced leg ischaemia with vasodilator function of the clinically unaffected brachial artery over the...

  • Antioxidants can prevent photoreceptor degeneration.  // Journal of Clinical Investigation;Mar2009, Vol. 119 Issue 3, p423 

    The article reports on a study which has revealed that mice lacking VLDL receptor (VLDLR) have a retinal phenotype similar to that observed in individuals with either a number of disease states, including macular telangiectasia (MacTel) and retinal angiomatous proliferation (RAP). It has also...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics